Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | CCR1 | P32246 | 3/20 | 0.58 |
| ▸ | CCR5 | P51681 | 3/20 | 0.58 |
| ▸ | CCR8 | P51685 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | METAP1 | P53582 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.58 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.56 |
| ▸ | TP53 | P04637 | 4/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30161801 | 1.00 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL19066619 | 0.98 | KDM4E (0.56) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29942654 | 0.87 | NPC1 (0.63) | KDM4ECYP1A2SMN1; SMN2ALOX15L3MBTL1 | |
| SCHEMBL29614829 | 0.87 | NPC1 (0.63) | KDM4ECYP1A2SMN1; SMN2ALOX15L3MBTL1 | |
| SCHEMBL29966674 | 0.87 | NPC1 (0.63) | KDM4ECYP1A2SMN1; SMN2ALOX15L3MBTL1 | |
| SCHEMBL3076524 | 0.87 | NPC1 (0.63) | KDM4ECYP1A2SMN1; SMN2ALOX15L3MBTL1 | |
| SCHEMBL13154419 | 0.84 | KDM4E (0.58) | KDM4ELMNACCR1CCR5CCR8 | |
| Phenazine SCHEMBL25380403 | 0.84 | KDM4E (0.74) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL12971527 | 0.82 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL11992044 | 0.82 | TGFBR1 (0.60) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113173927-A | Pyridyl quinoxaline delayed luminescence derivative and preparation method thereof | 南昌万季科技有限公司 | 2021-07-27 | — | — | CN | claimed |
| EP-3397642-A1 | DNA TARGETED MONO AND HETERODINUCLEAR COMPLEXES | Atilim Universitesi (TR) | 2018-11-07 | — | — | EP | claimed |
| WO-2017116356-A1 | DNA TARGETED MONO AND HETERODINUCLEAR COMPLEXES | ATILIM UNIVERSITESI (TR) | 2017-07-06 | — | — | WO | claimed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1377552-B1 | METAL COMPLEXES AND THERAPEUTIC USES THEREOF | UNIV SYDNEY (AU) | 2006-05-17 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040152686-A1 | Metal complexes and therapeutic uses thereof | THE UNIVERSITY OF WESTERN SYDNEY (AU) | 2004-08-05 | — | — | US | claimed |
| EP-1377552-A4 | METAL COMPLEXES AND THERAPEUTIC USES THEREOF | UNIV SYDNEY (AU) | 2004-06-16 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| EP-1377552-A1 | METAL COMPLEXES AND THERAPEUTIC USES THEREOF | University of Sydney (AU) | 2004-01-07 | — | — | EP | claimed |
| CN-1389443-A | Nicket compound catalyst for olefine oligomerization and its prepn. and application | CHINESE ACAD INST CHEMISTRY (CN) | 2003-01-08 | — | — | CN | claimed |
| WO-2002066435-A1 | METAL COMPLEXES AND THERAPEUTIC USES THEREOF | THE UNIVERSITY OF SYDNEY (AU) | 2002-08-29 | — | — | WO | claimed |
| CN-118324818-A | Metal iridium complex with photoactivation performance and preparation method and application thereof | 东南大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-113173927-A | Pyridyl quinoxaline delayed luminescence derivative and preparation method thereof | 南昌万季科技有限公司 | 2021-07-27 | — | — | CN | disclosed |
| CN-113173927-A | Pyridyl quinoxaline delayed luminescence derivative and preparation method thereof | 南昌万季科技有限公司 | 2021-07-27 | — | — | CN | disclosed |
| CN-1389443-A | Nicket compound catalyst for olefine oligomerization and its prepn. and application | CHINESE ACAD INST CHEMISTRY (CN) | 2003-01-08 | — | — | CN | disclosed |
| CN-1389443-A | Nicket compound catalyst for olefine oligomerization and its prepn. and application | CHINESE ACAD INST CHEMISTRY (CN) | 2003-01-08 | — | — | CN | disclosed |
| US-4297362-A | 4-(3,4-Diaminophenyl)pyridine or salts, and use thereof as cardiotonic | STERLING DRUG INC. (US) | 1981-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | KDM4E 1868/4885LMNA 178/4885CCR1 2624/4885 |
| US-20040152686-A1 | Metal complexes and therapeutic uses thereof | SOD1, PDCD1LG2, SLC30A5 | KDM4E 4186/4885LMNA 1585/4885CCR1 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.